Search

Your search keyword '"Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie"' showing total 451 results

Search Constraints

Start Over You searched for: Author "Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie" Remove constraint Author: "Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie"
451 results on '"Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie"'

Search Results

1. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

2. Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: Data from the early arthritis ESPOIR cohort

3. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review

4. Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

5. Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

6. Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study

7. Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE

8. 2016 update of the EULAR recommendations for the management of early arthritis

9. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

10. Th17 and regulatory T cells are increased in blood of patients with birdshot chorioretinopathy

11. TNF inhibitors increase fat mass in inflammatory rheumatic disease: a systematic review with meta-analysis

12. Mastitis associated with Sjögren’s syndrome: a series of nine cases

13. Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells

14. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis

15. Evolution of renal function in African patients initiating second line antiretroviral treatment: findings from the 2LADY-ANRS 12169 trial

16. Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

17. Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data

18. Deregulation and therapeutic potential of microRNAs in arthritic diseases

19. PET Adapted Salvage Therapy for Advanced Hodgkin Lymphomas: Towards the Suppression of Positive Interim PET Unfavorable Prognosis? a Report of the Goelams Multicentric Phase 2 Trial LH2007

20. Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: Development of recommendations for clinical practice based on published evidence and expert opinion

21. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)

22. Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR

23. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort

24. Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort

25. Biological and psychological predictors of posttraumatic stress disorder onset and chronicity. A one-year prospective study

26. Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort

27. Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice

28. AA amyloidosis treated with tocilizumab: case series and updated literature review

29. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

30. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort

31. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis

32. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study

33. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort

34. Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

35. Association of Anticyclic Citrullinated Peptide Antibodies and/or Rheumatoid Factor Status and Clinical Presentation in Early Arthritis: Results from the ESPOIR Cohort

36. Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring

37. Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis 'ESPOIR' cohort

38. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort

39. Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study

40. Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France

41. First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort

42. Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry

43. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

44. NAMPT/Visfatin expression by inflammatory monocytes mediates arthritis pathogenesis by promoting IL-17–producing T cells

45. OP0212 Phospholipid Transfer Protein (PLTP): A Link between Inflammation and Lipids in Rheumatoid Arthritis?

46. Prediction of radiographic damage in early arthritis by sonographic erosions and power Doppler signal: a longitudinal observational study

47. The NF-κB member p65 controls glutamine metabolism through miR-23a

48. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort

49. Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

50. La vitesse de progression radiologique annuelle initiale est un nouveau facteur de risque de prédiction de la dégradation articulaire ultérieure : les résultats de la cohorte ESPOIR

Catalog

Books, media, physical & digital resources